Ann Merchant
Direktor/Vorstandsmitglied bei ALVOTECH
Vermögen: 144 444 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Ann Merchant
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
312
| Public Company | Pharmaceuticals: Major | 312 |
38
| Public Company | Biotechnology | 38 |
23
| Public Company | Biotechnology | 23 |
Alvotech hf
 Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland.
14
| Subsidiary | Pharmaceuticals: Major | 14 |
| Public Company | Pharmaceuticals: Major | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ann Merchant
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Amgen Ventures LLC
 Amgen Ventures LLC Investment ManagersFinance Amgen Ventures LLC (Amgen Ventures) is a venture capital firm, a subsidiary of Amgen, Inc. founded in 2004. The firm is headquartered in Thousand Oaks, California. | Investment Managers | Corporate Officer/Principal Chief Operating Officer General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor Corporate Officer/Principal | |
| University of Iceland | College/University | Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Human Resources Officer | |
| LOTUS PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member Director of Finance/CFO | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
| GENELUX CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Director/Board Member Director/Board Member Undergraduate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal | |
| SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Kunwha Pharmaceutical Co., Ltd. | Director/Board Member Director/Board Member | ||
| UCLA Anderson School of Management | College/University | Masters Business Admin Masters Business Admin | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| KUNWHA PHARMACEUTICAL CO., LTD. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor | |
| HOSPIRA, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| JUNO THERAPEUTICS INC | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
Alvogen Pharma US, Inc.
 Alvogen Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Alvogen Pharma US, Inc. engages in the development, manufacturing and distributing generic, brand, over-the-counter brands and biosimilar products. The company was founded in March 2012 and is headquartered in Morristown, NJ. | Pharmaceuticals: Major | Chief Executive Officer President | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
Alvogen Iceland ehf
 Alvogen Iceland ehf Pharmaceuticals: MajorHealth Technology Alvogen Iceland ehf develops, manufactures and distributes generic pharmaceutical products. It offers Eradizol, Kalmente, Eubiotic, Windi, Zinkspray, and Aftamed. The company was founded in 2010 and is headquartered in Reykjavik, Iceland. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| ELIEM THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Masters Business Admin Graduate Degree | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree | |
Alvogen Emerging Markets Holdings Ltd.
 Alvogen Emerging Markets Holdings Ltd. Pharmaceuticals: MajorHealth Technology Part of Celtic Holdings SCA, Alvogen Emerging Markets Holdings Ltd. is a Chinese pharmaceutical company that offers high-quality, affordable generic medications to reduce healthcare costs globally. The company is based in Wanchai, Hong Kong. The company's growth strategy is fueled by a unique portfolio of high-quality and difficult-to-make pharmaceutical products. Alvogen's sister company, Alvotech, specializes in the development and manufacturing of high-quality biosimilar medicines. The company was founded in 2009 by Vilhelm Róbert Wessman, who has been the CEO since 2009. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Adalvo Ltd.
 Adalvo Ltd. Pharmaceuticals: MajorHealth Technology Adalvo Ltd. is a pharmaceutical company with headquarters in an undisclosed location and additional offices in over 15 countries. The private company is based in an undisclosed location and has subsidiaries in over 15 countries, including the United States and India. The Maltese company takes a unique and customized approach to help its partners achieve their business goals in the dynamic pharmaceutical sector. Adalvo is committed to accelerating the growth and development of its employees and local communities while striving for excellence in all its endeavors. The company's purpose-driven culture is focused on improving the lives of patients worldwide. Adalvo has a dynamic leadership team with significant experience and industry know-how. The CEO of the company is Anil Okay. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| Freie Universität Berlin | College/University | Doctorate Degree Graduate Degree | |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Director/Board Member Director/Board Member | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Maryland | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Doctorate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| METAGENOMI, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| ABBVIE INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| State University of New York at Buffalo | College/University | Masters Business Admin Graduate Degree | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree Doctorate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Graduate Degree | |
| BIOMARIN PHARMACEUTICAL INC. | Biotechnology | Director/Board Member Director/Board Member | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Noden Pharma DAC
 Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 37 |
| Deutschland | 5 |
| Island | 3 |
| Südkorea | 3 |
| Taiwan | 2 |
Sektoral
| Health Technology | 35 |
| Consumer Services | 14 |
| Finance | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 491 |
| Corporate Officer/Principal | 244 |
| Independent Dir/Board Member | 149 |
| Chairman | 95 |
| Chief Executive Officer | 82 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jerry D. Choate | 41 |
| Frank J. Biondi | 36 |
| Stephen Parker | 34 |
| Leonard Schaeffer | 32 |
| Marc M. P. de Garidel | 31 |
| Kathryn Falberg | 30 |
| Gerald Heinz Möller | 29 |
| Dennis Fenton | 28 |
| François de Carbonnel | 24 |
| Wendy Johnson | 23 |
| Vilhelm Wessman | 23 |
| Linda McGoldrick | 21 |
| Frank Morich | 21 |
| John Smither | 20 |
| Cynthia Patton | 20 |
- Börse
- Insiders
- Ann Merchant
- Unternehmensverbindungen